MediWound (MDWD) Income from Non-Controlling Interests (2014 - 2016)
MediWound (MDWD) posted quarterly Income from Non-Controlling Interests of -$27000.0 for Q4 2014, down 179.41% quarter-over-quarter from $34000.0 in Q3 2014.
MediWound (MDWD) Income from Non-Controlling Interests (2014 - 2016) Analysis & Trends
MediWound's Income from Non-Controlling Interests history runs 1 years deep, the most recent figure standing at -$27000.0 for Q4 2014.
- In Q4 2014, Income from Non-Controlling Interests changed N/A year-over-year to -$27000.0; the TTM figure through Sep 2015 stood at $24000.0 (changed N/A YoY), while the FY2014 annual figure was $14000.0, changed N/A from the prior year.
- Income from Non-Controlling Interests for Q4 2014 stood at -$27000.0, down from $34000.0 in the prior quarter.
- The five-year high for Income from Non-Controlling Interests was $34000.0 in Q3 2014, with the low at -$27000.0 in Q4 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 63.60 Mn |
| 10 | MediWound | 170.65 Mn | 139.65 Mn | 337,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2016 | 3,000.00 |
| Dec 31, 2015 | 1,000.00 |
| Mar 31, 2015 | 1,000.00 |
| Dec 31, 2014 | -27,000.00 |
| Sep 30, 2014 | 34,000.00 |
| Jun 30, 2014 | 17,000.00 |